Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Clinical studies of the effects of rubidium ions on the course of manic-depressive illness are reported. It seems that rubidium tends to increase the length of manic phases and possibly reduces the extremes of mood. Rubidium did not seem to produce any severe side effects in the dose administered, but it has a long biological half-life and caution is still required. Some details of the CSF, RBC, saliva and plasma and urine kinetics are also reported.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on